Fleury SA (FLRY3)

B3
Currency in BRL
12.13
-0.31(-2.49%)
Closed
FLRY3 Scorecard
Full Analysis
3 analysts have revised their earnings downwards for the upcoming period
Earnings results expected in 8 days
Fair Value
Day's Range
12.0412.46
52 wk Range
11.2116.60
Key Statistics
Edit
Bid/Ask
12.10 / 12.14
Prev. Close
12.13
Open
12.46
Day's Range
12.04-12.46
52 wk Range
11.21-16.6
Volume
4.14M
Average Volume (3m)
3.23M
1-Year Change
-19.22%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FLRY3 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
16.35
Upside
+34.75%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Fleury SA Company Profile

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including scheduling and performing teleconsultations, and face-to-face consultations, as well as scheduling and accessing diagnostic test results, electronic medical record, and self-manage health issues. It operates customer service units and hospital-based units under the Fleury, Felippe Mattoso, Labs a+, Diagnoson a+, Papaiz, Serdil, LAFE, Instituto de Radiologia de Natal, Centro de Patologia Clínica, Diagmax, Santécorp, a+SP, CIP, Saha, Moacir Cunha, Vita, e Campana, Methodos, Pretti, Bioclinico, a+PE, Marcelo Magalhaes, Inlab, Weinmann, a+, a+BA, IRN, CPC, and a+PI brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.

Employees
27000
Market
Brazil

Compare FLRY3 to Peers and Sector

Metrics to compare
FLRY3
Peers
Sector
Relationship
P/E Ratio
10.8x7.6x−0.7x
PEG Ratio
0.270.010.00
Price/Book
1.2x0.9x2.6x
Price / LTM Sales
0.9x0.8x3.1x
Upside (Analyst Target)
28.6%21.6%47.6%
Fair Value Upside
Unlock21.3%7.7%Unlock

Analyst Ratings

4 Buy
7 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 16.35
(+34.75% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.16
Dividend Yield
5.62%
Industry Median 0.99%
Annualised payout
0.6989
Paid unevenly
5-Years Growth
-6.01%
Growth Streak

Earnings

Latest Release
Nov 07, 2024
EPS / Forecast
0.345 / 0.3574
Revenue / Forecast
1.96B / 1.99B
EPS Revisions
Last 90 days

FAQ

What Is the FLEURY ON (FLRY3) Stock Price Today?

The FLEURY ON stock price today is 12.13

What Stock Exchange Does FLEURY ON Trade On?

FLEURY ON is listed and trades on the B3 stock exchange.

What Is the Stock Symbol for FLEURY ON?

The stock symbol for FLEURY ON is "FLRY3."

Does FLEURY ON Pay Dividends? What’s The Current Dividend Yield?

The FLEURY ON dividend yield is 5.61%.

What Is the FLEURY ON Market Cap?

As of today, FLEURY ON market cap is 6.58B.

What is FLEURY ON Earnings Per Share?

The FLEURY ON EPS is 1.16.

What Is the Next FLEURY ON Earnings Date?

FLEURY ON will release its next earnings report on 26 Feb 2025.

From a Technical Analysis Perspective, Is FLRY3 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.